hydroxychloroquine has been researched along with Cirrhosis, Liver in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ursodeoxycholic acid (UDCA) has been widely used in the treatment of primary biliary cholangitis (PBC) with chronic liver fibrosis, but its detailed mechanism remains unclear." | 1.56 | Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy. ( Chen, L; Chen, XZ; Wu, PB; Ye, HL; Zhang, G; Zhang, JW, 2020) |
| "The novel coronavirus disease 2019 (COVID-19) is a highly infectious and rapidly spreading disease." | 1.56 | Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. ( Avdic, E; Avery, R; Cameron, AM; Chen, PH; Fine, DM; Garibaldi, B; Garneau, WM; Gurakar, A; Hammami, MB; Jain, T; Kim, AK; Liu, G; Monroy Trujillo, JM; Niranjan-Azadi, A; Petty, B; Shah, P; Strout, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, HL | 1 |
| Zhang, JW | 1 |
| Chen, XZ | 1 |
| Wu, PB | 1 |
| Chen, L | 1 |
| Zhang, G | 1 |
| Hammami, MB | 1 |
| Garibaldi, B | 1 |
| Shah, P | 1 |
| Liu, G | 1 |
| Jain, T | 1 |
| Chen, PH | 1 |
| Kim, AK | 1 |
| Avdic, E | 1 |
| Petty, B | 1 |
| Strout, S | 1 |
| Fine, DM | 1 |
| Niranjan-Azadi, A | 1 |
| Garneau, WM | 1 |
| Cameron, AM | 1 |
| Monroy Trujillo, JM | 1 |
| Gurakar, A | 1 |
| Avery, R | 1 |
2 other studies available for hydroxychloroquine and Cirrhosis, Liver
| Article | Year |
|---|---|
Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.
Topics: Animals; Autophagy; Blotting, Western; Cell Line; Disease Models, Animal; Humans; Hydroxychloroquine | 2020 |
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report.
Topics: Antibodies, Monoclonal, Humanized; Carcinoma, Hepatocellular; Coronavirus Infections; COVID-19; COVI | 2020 |